PHD Progress Of Disease In Prediabetic And Prehypertensive Patients In Malawi: Assessment Of Risk Factors And Complications 2017-18 (Karonga and Lilongwe combined analytical dataset)
Malawi
Get Microdata
Reference ID
MWI-MEIRU-combined-PHD-data-v01
Collections
Created on
Nov 14, 2025
Last modified
Nov 15, 2025
Page views
34292
Downloads
94
- Data files
- phd_combined_final
whether blood sample for lipids testing was fasted (D) (b_basefoll_lip)
Data file: phd_combined_final
Overview
Valid:
792
Invalid:
73
Type:
Discrete
Decimal:
0
Start:
2002
End:
2004
Width:
3
Range:
1 - 999
Format:
Numeric
Questions and instructions
Literal question
SEE NCD COMBINED DOCUMENTATION
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | Visit 1 | 0 |
0%
|
| 2 | TSD/GSC-2 month follow up | 0 |
0%
|
| 3 | ART-2 month follow up | 0 |
0%
|
| 4 | Visit 4 | 0 |
0%
|
| 6 | 6 month follow up | 0 |
0%
|
| 8 | 8 week follow up | 0 |
0%
|
| 9 | 9 month follow up | 0 |
0%
|
| 10 | 10 week follow up | 0 |
0%
|
| 12 | 12 month follow up | 0 |
0%
|
| 14 | 14 week follow up | 0 |
0%
|
| 15 | 15 month follow up | 0 |
0%
|
| 16 | 16 week follow up | 0 |
0%
|
| 18 | 18 month follow up | 0 |
0%
|
| 21 | 21 month follow up | 0 |
0%
|
| 24 | 24 month follow up | 0 |
0%
|
| 26 | 26 week follow up | 0 |
0%
|
| 27 | 27 month follow up | 0 |
0%
|
| 30 | 30 month follow up | 0 |
0%
|
| 33 | 33 month follow up | 0 |
0%
|
| 36 | 36 month follow up | 0 |
0%
|
| 39 | 39 month follow up | 0 |
0%
|
| 42 | 42 month follow up | 0 |
0%
|
| 52 | ??? | 0 |
0%
|
| 100 | Week O6 - Control | 0 |
0%
|
| 101 | Week 26 - Control | 0 |
0%
|
| 102 | Acute episode | 0 |
0%
|
| 103 | AHS-Stage 1 | 0 |
0%
|
| 104 | ARV-Stage 1 | 0 |
0%
|
| 105 | Baby 1 | 0 |
0%
|
| 106 | Baseline fasting | 791 |
99.9%
|
| 107 | Baseline | 0 |
0%
|
| 108 | Baseline random | 1 |
0.1%
|
| 109 | Child's sample | 0 |
0%
|
| 110 | Cord blood | 0 |
0%
|
| 111 | excluded - LIS hiv positives | 0 |
0%
|
| 113 | Follow up | 0 |
0%
|
| 114 | Glucose tolerance | 0 |
0%
|
| 115 | iohex 1 | 0 |
0%
|
| 116 | iohex 2 | 0 |
0%
|
| 117 | iohex 3 | 0 |
0%
|
| 118 | iohex 4 | 0 |
0%
|
| 119 | IIB follow up 1 | 0 |
0%
|
| 120 | Initial screening | 0 |
0%
|
| 121 | LIS clinical review | 0 |
0%
|
| 122 | Mother's sample | 0 |
0%
|
| 123 | Old - toxoplasmosis test required | 0 |
0%
|
| 124 | Old | 0 |
0%
|
| 125 | Pre baseline | 0 |
0%
|
| 126 | Gates Controls suspected to be progressor | 0 |
0%
|
| 127 | PVC follow up week 1 | 0 |
0%
|
| 128 | PVC 12 week follow up | 0 |
0%
|
| 129 | PVC 18 week follow up | 0 |
0%
|
| 130 | PVC 4 week follow up | 0 |
0%
|
| 131 | PVC 6 week follow up | 0 |
0%
|
| 132 | Randomisation screening | 0 |
0%
|
| 133 | Stimulated with BCG | 0 |
0%
|
| 134 | Unstimulated | 0 |
0%
|
| 135 | Young - sickle cell test and toxoplasmosis test required | 0 |
0%
|
| 136 | Young - sickle cell test | 0 |
0%
|
| 137 | NTN pilot1 | 0 |
0%
|
| 998 | Unknown | 0 |
0%
|
| 999 | Missing | 0 |
0%
|
| Sysmiss | 73 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Description
Definition
SEE NCD COMBINED DOCUMENTATION
Imputation and derivation
Derivation
variable: version (table[s]: NCD_combined_data_all_final [derived table])
Others
Notes
Valid stage in val_lab_tests at the time the sample was entered
in cases where the same code had different labels, duplicates were recoded differently ; in cases where different codes had the same label, the labels were prefixed with the code for the study in which the sample was collected ;
in cases where the same code had different labels, duplicates were recoded differently ; in cases where different codes had the same label, the labels were prefixed with the code for the study in which the sample was collected ;